Amedisys Inc (AMED) 48.10 $AMED Amedisys Closes
Post# of 273258
Posted On: 09/02/2016 7:09:10 AM
Amedisys Inc (AMED) 48.10 $AMED
Amedisys Closes Professional Profiles Acquisition
GlobeNewswire - 8 mins ago
Amedisys, Inc. (NASDAQ:AMED), one of America's leading home health and hospice companies, as of September 1, 2016, has closed on the previously announced acquisition of Professional Profiles, Inc., for $4.4 million.
AMED: 48.10 (-0.03)
Amedisys to Present at Investor Conferences
GlobeNewswire - Tue Aug 30, 11:00AM CDT
Amedisys, Inc. (NASDAQ:AMED), one of America's leading home health and hospice companies, today announced that it will participate in the following upcoming investor conferences:
AMED: 48.10 (-0.03)
Update in Lawsuit for Investors in Amedisys Inc (NASDAQ:AMED) shares announced by Shareholders Foundation
GlobeNewswire - Tue Aug 30, 9:05AM CDT
The Shareholders Foundation, Inc. announces that a lawsuit is pending in Louisiana on behalf of certain purchasers of shares of Amedisys Inc (NASDAQ:AMED) over alleged Securities Laws Violations by Amedisys Inc.
AMED: 48.10 (-0.03)
Amedisys (AMED) Down 5% Despite Q2 Earnings and Revenue Beat
Zacks Equity Research - Zacks Investment Research - Thu Aug 04, 8:15AM CDT
Amedisys Inc. (AMED) reported adjusted earnings from continuing operations of 42 cents per share in the second quarter of 2016.
AMSG: 65.40 (+0.48), AFAM: 36.41 (-0.42), BIOS: 2.57 (-0.01), AMED: 48.10 (-0.03)
Downgrade Alert for Amedisys (AMED)
Comtex SmarTrend(R) - Thu Aug 04, 3:40AM CDT
Amedisys (NASDAQ:AMED) was downgraded from Buy to Neutral at Mizuho today. The stock closed yesterday at $51.08 on volume of 1.9 million shares, above average daily volume of 324,000. In the past 52 weeks, shares of Amedisys have traded between a low of $26.05 and a high of $55.16 and closed yesterday at $51.08, which is 96% above that low price. In the last five trading sessions, the 50-day moving average (MA) has climbed 2.6% while the 200-day MA has risen 0.3%.
AMED: 48.10 (-0.03)
After Yesterday's Decline of 5.71%, Amedisys Offers Investors Better Value
Comtex SmarTrend(R) - Wed Aug 03, 2:01PM CDT
Amedisys (NASDAQ:AMED) traded in a range yesterday that spanned from a low of $45.48 to a high of $51.16. Yesterday, the shares fell 5.7%, which took the trading range below the 3-day low of $51.44 on volume of 1.2 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
AMED: 48.10 (-0.03)
Amedisys Reports Second Quarter Financial Results
GlobeNewswire - Tue Aug 02, 6:29PM CDT
ANNOUNCES EXECUTIVE RETIREMENT
AMED: 48.10 (-0.03)
Amedisys Announces Definitive Agreement to Acquire Professional Profiles, Inc.
GlobeNewswire - Mon Aug 01, 6:00AM CDT
Amedisys, Inc. (NASDAQ:AMED), one of the nation's leading home health care and hospice companies, today announced that it has signed a definitive agreement to acquire Professional Profiles, Inc., a personal care company with corporate headquarters in Danvers, Massachusetts. Under the terms of the agreement, Amedisys will acquire substantially all of the assets of Professional Profiles, Inc., for $4.4 million. The transaction is expected to close on September 1, 2016.
AMED: 48.10 (-0.03)
Amedisys Brings In David B. Pearce As New Chief Compliance Officer
GlobeNewswire - Fri Jun 17, 7:00AM CDT
David B. Pearce will join Amedisys, Inc. (NASDAQ:AMED), as Senior Vice President and Chief Compliance Officer, effective July 5.
AMED: 48.10 (-0.03)
38.5% Return Seen to Date on SmarTrend Amedisys Call (AMED)
Comtex SmarTrend(R) - Mon Jun 13, 1:09PM CDT
SmarTrend identified an Uptrend for Amedisys (NASDAQ:AMED) on February 16th, 2016 at $36.58. In approximately 4 months, Amedisys has returned 38.55% as of today's recent price of $50.68.
AMED: 48.10 (-0.03)
Shares of AMED Up 43.1% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Fri Jun 03, 12:51PM CDT
SmarTrend identified an Uptrend for Amedisys (NASDAQ:AMED) on February 16th, 2016 at $36.58. In approximately 4 months, Amedisys has returned 43.12% as of today's recent price of $52.36.
AMED: 48.10 (-0.03)
Amedisys to Present at the Jefferies 2016 Healthcare Conference
GlobeNewswire - Wed Jun 01, 3:00PM CDT
Amedisys, Inc. (NASDAQ:AMED), one of America's leading healthcare at home companies, today announced that Paul B. Kusserow, President and Chief Executive Officer, will present at the Jefferies 2016 Healthcare Conference in New York, NY on Wednesday, June 8, 2016.
AMED: 48.10 (-0.03)
Uptrend Call Working As Amedisys Stock Rises 39.9% (AMED)
Comtex SmarTrend(R) - Fri May 27, 12:30AM CDT
SmarTrend identified an Uptrend for Amedisys (NASDAQ:AMED) on February 16th, 2016 at $36.58. In approximately 3 months, Amedisys has returned 39.94% as of today's recent price of $51.19.
AMED: 48.10 (-0.03)
Amedisys Has Returned 37.8% Since SmarTrend Recommendation (AMED)
Comtex SmarTrend(R) - Thu May 19, 12:56PM CDT
SmarTrend identified an Uptrend for Amedisys (NASDAQ:AMED) on February 16th, 2016 at $36.58. In approximately 3 months, Amedisys has returned 37.75% as of today's recent price of $50.39.
AMED: 48.10 (-0.03)
Amedisys Up 40.8% Since SmarTrend Uptrend Call (AMED)
Comtex SmarTrend(R) - Thu May 12, 12:26AM CDT
SmarTrend identified an Uptrend for Amedisys (NASDAQ:AMED) on February 16th, 2016 at $36.58. In approximately 3 months, Amedisys has returned 40.76% as of today's recent price of $51.49.
AMED: 48.10 (-0.03)
Amedisys to Present at the Bank of America Merrill Lynch Health Care Conference
GlobeNewswire - Fri May 06, 9:00AM CDT
Amedisys, Inc. (NASDAQ:AMED), one of America's leading healthcare at home companies, today announced that Paul B. Kusserow, President and Chief Executive Officer, will present at the 2016 Bank of America Merrill Lynch Health Care Conference in Las Vegas, NV on Tuesday, May 10, 2016.
AMED: 48.10 (-0.03)
Amedisys (AMED) Lags Q1 Earnings, Revenues Top the Mark
Zacks Equity Research - Zacks Investment Research - Fri May 06, 8:56AM CDT
Amedisys Inc. (AMED) reported adjusted earnings from continuing operations of 33 cents per share in the first quarter of 2016.
BSX: 24.33 (+0.51), AFAM: 36.41 (-0.42), AMED: 48.10 (-0.03), HLS: 40.20 (-0.51)
Amedisys Reports First Quarter Financial Results
GlobeNewswire - Tue May 03, 4:31PM CDT
Amedisys, Inc. (NASDAQ:AMED), a leading home health and hospice company, today reported its financial results for the three-month period ended March 31, 2016.
AMED: 48.10 (-0.03)
Chemed (CHE) Q1 Earnings Miss the Mark, Revenues in Line
Zacks Equity Research - Zacks Investment Research - Mon May 02, 9:53AM CDT
Chemed Corp. (CHE) reported first-quarter 2016 adjusted earnings per share (EPS) of $1.53.
CHE: 134.95 (+0.02), AFAM: 36.41 (-0.42), AMED: 48.10 (-0.03), HLS: 40.20 (-0.51)
Amedisys Closes Professional Profiles Acquisition
GlobeNewswire - 8 mins ago
Amedisys, Inc. (NASDAQ:AMED), one of America's leading home health and hospice companies, as of September 1, 2016, has closed on the previously announced acquisition of Professional Profiles, Inc., for $4.4 million.
AMED: 48.10 (-0.03)
Amedisys to Present at Investor Conferences
GlobeNewswire - Tue Aug 30, 11:00AM CDT
Amedisys, Inc. (NASDAQ:AMED), one of America's leading home health and hospice companies, today announced that it will participate in the following upcoming investor conferences:
AMED: 48.10 (-0.03)
Update in Lawsuit for Investors in Amedisys Inc (NASDAQ:AMED) shares announced by Shareholders Foundation
GlobeNewswire - Tue Aug 30, 9:05AM CDT
The Shareholders Foundation, Inc. announces that a lawsuit is pending in Louisiana on behalf of certain purchasers of shares of Amedisys Inc (NASDAQ:AMED) over alleged Securities Laws Violations by Amedisys Inc.
AMED: 48.10 (-0.03)
Amedisys (AMED) Down 5% Despite Q2 Earnings and Revenue Beat
Zacks Equity Research - Zacks Investment Research - Thu Aug 04, 8:15AM CDT
Amedisys Inc. (AMED) reported adjusted earnings from continuing operations of 42 cents per share in the second quarter of 2016.
AMSG: 65.40 (+0.48), AFAM: 36.41 (-0.42), BIOS: 2.57 (-0.01), AMED: 48.10 (-0.03)
Downgrade Alert for Amedisys (AMED)
Comtex SmarTrend(R) - Thu Aug 04, 3:40AM CDT
Amedisys (NASDAQ:AMED) was downgraded from Buy to Neutral at Mizuho today. The stock closed yesterday at $51.08 on volume of 1.9 million shares, above average daily volume of 324,000. In the past 52 weeks, shares of Amedisys have traded between a low of $26.05 and a high of $55.16 and closed yesterday at $51.08, which is 96% above that low price. In the last five trading sessions, the 50-day moving average (MA) has climbed 2.6% while the 200-day MA has risen 0.3%.
AMED: 48.10 (-0.03)
After Yesterday's Decline of 5.71%, Amedisys Offers Investors Better Value
Comtex SmarTrend(R) - Wed Aug 03, 2:01PM CDT
Amedisys (NASDAQ:AMED) traded in a range yesterday that spanned from a low of $45.48 to a high of $51.16. Yesterday, the shares fell 5.7%, which took the trading range below the 3-day low of $51.44 on volume of 1.2 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
AMED: 48.10 (-0.03)
Amedisys Reports Second Quarter Financial Results
GlobeNewswire - Tue Aug 02, 6:29PM CDT
ANNOUNCES EXECUTIVE RETIREMENT
AMED: 48.10 (-0.03)
Amedisys Announces Definitive Agreement to Acquire Professional Profiles, Inc.
GlobeNewswire - Mon Aug 01, 6:00AM CDT
Amedisys, Inc. (NASDAQ:AMED), one of the nation's leading home health care and hospice companies, today announced that it has signed a definitive agreement to acquire Professional Profiles, Inc., a personal care company with corporate headquarters in Danvers, Massachusetts. Under the terms of the agreement, Amedisys will acquire substantially all of the assets of Professional Profiles, Inc., for $4.4 million. The transaction is expected to close on September 1, 2016.
AMED: 48.10 (-0.03)
Amedisys Brings In David B. Pearce As New Chief Compliance Officer
GlobeNewswire - Fri Jun 17, 7:00AM CDT
David B. Pearce will join Amedisys, Inc. (NASDAQ:AMED), as Senior Vice President and Chief Compliance Officer, effective July 5.
AMED: 48.10 (-0.03)
38.5% Return Seen to Date on SmarTrend Amedisys Call (AMED)
Comtex SmarTrend(R) - Mon Jun 13, 1:09PM CDT
SmarTrend identified an Uptrend for Amedisys (NASDAQ:AMED) on February 16th, 2016 at $36.58. In approximately 4 months, Amedisys has returned 38.55% as of today's recent price of $50.68.
AMED: 48.10 (-0.03)
Shares of AMED Up 43.1% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Fri Jun 03, 12:51PM CDT
SmarTrend identified an Uptrend for Amedisys (NASDAQ:AMED) on February 16th, 2016 at $36.58. In approximately 4 months, Amedisys has returned 43.12% as of today's recent price of $52.36.
AMED: 48.10 (-0.03)
Amedisys to Present at the Jefferies 2016 Healthcare Conference
GlobeNewswire - Wed Jun 01, 3:00PM CDT
Amedisys, Inc. (NASDAQ:AMED), one of America's leading healthcare at home companies, today announced that Paul B. Kusserow, President and Chief Executive Officer, will present at the Jefferies 2016 Healthcare Conference in New York, NY on Wednesday, June 8, 2016.
AMED: 48.10 (-0.03)
Uptrend Call Working As Amedisys Stock Rises 39.9% (AMED)
Comtex SmarTrend(R) - Fri May 27, 12:30AM CDT
SmarTrend identified an Uptrend for Amedisys (NASDAQ:AMED) on February 16th, 2016 at $36.58. In approximately 3 months, Amedisys has returned 39.94% as of today's recent price of $51.19.
AMED: 48.10 (-0.03)
Amedisys Has Returned 37.8% Since SmarTrend Recommendation (AMED)
Comtex SmarTrend(R) - Thu May 19, 12:56PM CDT
SmarTrend identified an Uptrend for Amedisys (NASDAQ:AMED) on February 16th, 2016 at $36.58. In approximately 3 months, Amedisys has returned 37.75% as of today's recent price of $50.39.
AMED: 48.10 (-0.03)
Amedisys Up 40.8% Since SmarTrend Uptrend Call (AMED)
Comtex SmarTrend(R) - Thu May 12, 12:26AM CDT
SmarTrend identified an Uptrend for Amedisys (NASDAQ:AMED) on February 16th, 2016 at $36.58. In approximately 3 months, Amedisys has returned 40.76% as of today's recent price of $51.49.
AMED: 48.10 (-0.03)
Amedisys to Present at the Bank of America Merrill Lynch Health Care Conference
GlobeNewswire - Fri May 06, 9:00AM CDT
Amedisys, Inc. (NASDAQ:AMED), one of America's leading healthcare at home companies, today announced that Paul B. Kusserow, President and Chief Executive Officer, will present at the 2016 Bank of America Merrill Lynch Health Care Conference in Las Vegas, NV on Tuesday, May 10, 2016.
AMED: 48.10 (-0.03)
Amedisys (AMED) Lags Q1 Earnings, Revenues Top the Mark
Zacks Equity Research - Zacks Investment Research - Fri May 06, 8:56AM CDT
Amedisys Inc. (AMED) reported adjusted earnings from continuing operations of 33 cents per share in the first quarter of 2016.
BSX: 24.33 (+0.51), AFAM: 36.41 (-0.42), AMED: 48.10 (-0.03), HLS: 40.20 (-0.51)
Amedisys Reports First Quarter Financial Results
GlobeNewswire - Tue May 03, 4:31PM CDT
Amedisys, Inc. (NASDAQ:AMED), a leading home health and hospice company, today reported its financial results for the three-month period ended March 31, 2016.
AMED: 48.10 (-0.03)
Chemed (CHE) Q1 Earnings Miss the Mark, Revenues in Line
Zacks Equity Research - Zacks Investment Research - Mon May 02, 9:53AM CDT
Chemed Corp. (CHE) reported first-quarter 2016 adjusted earnings per share (EPS) of $1.53.
CHE: 134.95 (+0.02), AFAM: 36.41 (-0.42), AMED: 48.10 (-0.03), HLS: 40.20 (-0.51)
(0)
(0)Scroll down for more posts ▼